Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
493M
-
Number of holders
-
160
-
Total 13F shares, excl. options
-
84.7M
-
Shares change
-
+13.9M
-
Total reported value, excl. options
-
$2.67B
-
Value change
-
+$416M
-
Put/Call ratio
-
8.97
-
Number of buys
-
118
-
Number of sells
-
-81
-
Price
-
$31.53
Significant Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN) as of Q4 2018
216 filings reported holding ELAN - Elanco Animal Health Inc - COMMON STOCK as of Q4 2018.
Elanco Animal Health Inc - COMMON STOCK (ELAN) has 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 84.7M shares
of 493M outstanding shares and own 17.18% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (8.97M shares), Vanguard Group Inc (6.25M shares), AMUNDI PIONEER ASSET MANAGEMENT INC (5.77M shares), PRIMECAP MANAGEMENT CO/CA/ (4.96M shares), FMR LLC (4.42M shares), WELLINGTON MANAGEMENT GROUP LLP (3.94M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (3.52M shares), FRANKLIN RESOURCES INC (3.02M shares), WADDELL & REED FINANCIAL INC (3M shares), and WELLS FARGO & COMPANY/MN (2.9M shares).
This table shows the top 160 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.